Cytokine molecular therapy for intervention of virus infection
干预病毒感染的细胞因子分子治疗
基本信息
- 批准号:18591131
- 负责人:
- 金额:$ 2.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2006
- 资助国家:日本
- 起止时间:2006 至 2007
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Interleukin-27 (IL-27) is a heterodimeric cytokine composed of two polypeptide subunits, IL-27 p28 and EBV-induced protein 3 (Ebi3). The IL-27 signal is mediated through the heterodimeric receptor complex that consists of IL-27R_(WSX-1, TCCR)and gp130 and is expressed on various cells including naive CD4 positive T cells. Activation of JAK1/STAT1 pathway is crucially involved in the signal transduction downstream of the IL-27R complex. IL-27 provokes naive CD4 positive T cells to express T-bet and, subsequently, IL-12R62. IL-27 sequentially cooperates with IL-12 to induce initiation and maintenance of Th1 immune responses. IL-27 also synergize with IL-12 to induce interferon (IFN)-y production. Recently it was shown that generation of Th17 cells is suppressed by IL-27 in a STAT1 dependent manner. Taken together, IL-27 is involved in the key step for Th1 commitment where naive Th precursor cells commence differentiation into Th1 cells, and it is now considered that IL-27 is associated w … More ith many human diseases including malignant, allergic and inflammatory disorders. In this project, we found that IL-27 is also involved in a novel defense mechanism against virus infection. C57BI/6 mice that had been infected with Encephalomyocarditis virus (EMCV) were transfected in vivo with IL-27 gene, and their longevity was analyzed. All the control mice that received the virus but not IL-27 gene died within 10 days after the infection, whereas survival rate of the IL-27 gene-transfected mice remained 100% during this period. To clarify the mechanism of the anti-virus activity of IL-27, we also performed in vitro experiments, which strongly suggested that IL-27 directly acted on virus-infected cardiomyocytes to suppress virus replication, whereas induction of acquired immune responses did not contribute to the virus clearance. As an intracellular innate machinery against virus infection, MDA5-mediated pathway is widely known, but little is known on molecular mechanisms to regulate MDA5 expression. Then we assessed whether MDA5 participates in the IL-27-mediated virus suppression. Primary cardiac muscle cells were established form the day 16 mouse embryos and stimulated with IL-27, which led to drastic induction of mRNA for MDA5. Infected with EMCV, the IL-27-treated cells showed massive production of IFN-6 immediately after the infection, which was in sharp contrast to the lower level of IFN production by the cells that were not treated with IL-27. Specific silencing of MDA5 by means of the short interfering RNA completely cancelled the and-virus effect that was otherwise produced in cardiomyocytes after the IL-27 provocation. These findings indicate that IL-27 signaling augments expression of MDA5 in cardiac muscle cells, resulting in a strengthening of MDA5 pathway triggered by virus infection, which in turn generates robust induction of type I IFN at an early phase of infection to effectively suppress virus replication. Less
白细胞介素-27(IL-27)是由IL-27 p28和EBV诱导蛋白3(Ebi 3)两个多肽亚基组成的异源二聚体细胞因子。IL-27信号通过由IL-27 R_(WSX-1,TCCR)和gp 130组成的异源二聚体受体复合物介导,并在包括初始CD 4阳性T细胞在内的多种细胞上表达。JAK 1/STAT 1通路的激活在IL-27 R复合物下游的信号转导中至关重要。IL-27激发初始CD 4阳性T细胞表达T-bet,随后表达IL-12 R62。IL-27依次与IL-12协同诱导Th 1免疫应答的启动和维持。IL-27还与IL-12协同诱导干扰素(IFN)-γ产生。最近显示,IL-27以STAT 1依赖性方式抑制Th 17细胞的产生。综上所述,IL-27参与了Th 1定型的关键步骤,其中初始Th前体细胞开始分化为Th 1细胞,现在认为IL-27与Th 1细胞的分化有关。 ...更多信息 与包括恶性、过敏性和炎性病症在内的许多人类疾病相关。在这个项目中,我们发现IL-27也参与了一种新的抗病毒感染的防御机制。用IL-27基因转染脑心肌炎病毒(Encephalomyocarditis virus,EMCV)感染的C57 BI/6小鼠,观察其寿命。所有接受病毒但未接受IL-27基因的对照小鼠在感染后10天内死亡,而IL-27基因转染小鼠的存活率在此期间保持100%。为了阐明IL-27抗病毒活性的机制,我们还进行了体外实验,这强烈地表明IL-27直接作用于病毒感染的心肌细胞以抑制病毒复制,而诱导获得性免疫应答并不有助于病毒清除。MDA 5介导的途径作为抗病毒感染的细胞内先天机制已广为人知,但对调节MDA 5表达的分子机制知之甚少。然后我们评估了MDA 5是否参与IL-27介导的病毒抑制。从第16天的小鼠胚胎建立原代心肌细胞,并用IL-27刺激,这导致MDA 5的mRNA的急剧诱导。用EMCV感染,IL-27处理的细胞在感染后立即显示出大量的IFN-6产生,这与未用IL-27处理的细胞的较低水平的IFN产生形成鲜明对比。特异性沉默的MDA 5的短干扰RNA的装置完全取消了和病毒的影响,否则产生的心肌细胞后,IL-27的挑衅。这些发现表明,IL-27信号转导增强心肌细胞中MDA 5的表达,导致由病毒感染触发的MDA 5途径的加强,这反过来在感染的早期阶段产生I型IFN的强诱导,以有效抑制病毒复制。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
lnterleukin-21(lL-21)administration into the nostril alleviates murine allergic rhinitis
将白细胞介素 21 (lL-21) 注入鼻孔可缓解小鼠过敏性鼻炎
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Hiromura;Y.;et. al.
- 通讯作者:et. al.
Interleukin-21 (IL-21) administration into the nostril alleviates murine allergic rhinitis
将白细胞介素 21 (IL-21) 注入鼻孔可缓解小鼠过敏性鼻炎
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Hiromura;Y.;T. Kishida;H. Nakano;T. Hama;J. Imanishi;Y. Hisa;O. Mazda
- 通讯作者:O. Mazda
Interferon-y Is Causatively Involved in Experimental Inflammatory Bowel Disease in Mice
干扰素-y 与小鼠实验性炎症性肠病有关
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Ito;R.;M. Shin-Ya;T. Kishida;A. Urano;R. Takada;J. Sakagami;J. Imanishi;M. Kita;Y. Ueda;Y. Iwakura;Keisho;Kataoka;T. Okanoue;O. Mazda
- 通讯作者:O. Mazda
IL-21 Triggers both Cellular and Humoral Immune Responses Leading to Therapeutic Antitumor Effects against Head and Neck Squamous Cell Carcinoma.
IL-21 触发细胞和体液免疫反应,从而产生针对头颈鳞状细胞癌的治疗性抗肿瘤作用。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Nakano;H.;T.Kishida;H.asada;M.Shin-Ya;T.Shinomiya;J.Imanishi;T.Shimada;S.Nakai;M.Takeuchi;Y.Hisa;*O.Mazda
- 通讯作者:*O.Mazda
Therapeutic RNA Interference of malignant malanoma by electrotransfer of small interfering RNA targeting Mitf.
通过电转移靶向 Mitf 的小干扰 RNA 来治疗性 RNA 干扰恶性恶性瘤。
- DOI:
- 发表时间:2007
- 期刊:
- 影响因子:0
- 作者:Nakai;N.;T.Kishida;M.Shin-Ya;J.Imanishi;Y.Ueda;S.Kisjimoto;*O.Mazda
- 通讯作者:*O.Mazda
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KISHIDA Tsunao其他文献
KISHIDA Tsunao的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KISHIDA Tsunao', 18)}}的其他基金
Establishment of a procedure to eliminate viral sequences by means of the chromosome editing
建立通过染色体编辑消除病毒序列的程序
- 批准号:
26670485 - 财政年份:2014
- 资助金额:
$ 2.47万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Toward novel molecular targeting strategies for the metabolic syndrome
代谢综合征的新型分子靶向策略
- 批准号:
23591318 - 财政年份:2011
- 资助金额:
$ 2.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
相似国自然基金
基于CRISPR/Cas9文库筛选蜱传病毒Tamdy virus感染相关宿主因子及其作用机制的研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
苹果茎沟病毒(Apple stem grooving virus, ASGV)CP基因介导的RNAi 转基因对ASGV侵染和脱毒的影响研究
- 批准号:31801709
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
用Sindbis virus系统稳定表达HIV-1病毒样颗粒与抗HIV-1中和抗体诱导
- 批准号:30371317
- 批准年份:2003
- 资助金额:20.0 万元
- 项目类别:面上项目
相似海外基金
Bovine herpesvirus 4 as a vaccine platform for African swine fever virus antigens in pigs
牛疱疹病毒 4 作为猪非洲猪瘟病毒抗原的疫苗平台
- 批准号:
BB/Y006224/1 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Research Grant
Collaborative Research: TRTech-PGR TRACK: Discovery and characterization of small CRISPR systems for virus-based delivery of heritable editing in plants.
合作研究:TRTech-PGR TRACK:小型 CRISPR 系统的发现和表征,用于基于病毒的植物遗传编辑传递。
- 批准号:
2334028 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Standard Grant
Advancing entirely virus-free CRISPR CAR T cells to clinic- Are they as good as lentiviral CAR?
将完全无病毒的CRISPR CAR T细胞推向临床——它们和慢病毒CAR一样好吗?
- 批准号:
MR/Y503496/1 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Research Grant
Unravelling dengue virus structural dynamics and conformational changes using high-speed atomic force microscopy
使用高速原子力显微镜揭示登革热病毒结构动力学和构象变化
- 批准号:
24K18450 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Influence of RNA on icosahedral virus particle structure
RNA对二十面体病毒颗粒结构的影响
- 批准号:
BB/Y005732/1 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Research Grant
Understanding differences in host responses to African swine fever virus
了解宿主对非洲猪瘟病毒反应的差异
- 批准号:
BB/Z514457/1 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Fellowship
Expanding the Reach of Harwell Open Week: Virus Factory in Schools
扩大哈威尔开放周的影响范围:学校的病毒工厂
- 批准号:
ST/Y005813/1 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Research Grant
Application of the virus-like particle (VLP) technology in the development of anti-tick vaccine, utilizing novel salivary proteins from Haemaphysalis longicornis ticks.
利用长角血蜱的新型唾液蛋白,应用病毒样颗粒(VLP)技术开发抗蜱疫苗。
- 批准号:
24K18027 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
MFB: Partnerships to Transform Emerging Industries - RNA Tools/Biotechnology: Stabilizing Hairpin Inserts in RNA Virus Induced Gene Silencing Vectors
MFB:合作变革新兴产业 - RNA 工具/生物技术:稳定 RNA 病毒诱导基因沉默载体中的发夹插入
- 批准号:
2330663 - 财政年份:2024
- 资助金额:
$ 2.47万 - 项目类别:
Standard Grant














{{item.name}}会员




